Cargando…
Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice
Type 2 diabetes (T2D) and Alzheimer’s disease (AD) share several common pathophysiological features. Huperzine A (Hup A), a Lycopodium alkaloid extracted from the Chinese herb moss Huperzia serrata, is a specific and reversible inhibitor of acetylcholinesterase, which is clinically used for the trea...
Autores principales: | Wang, Hong-ying, Wu, Min, Diao, Jun-ling, Li, Ji-bin, Sun, Yu-xiang, Xiao, Xiao-qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471460/ https://www.ncbi.nlm.nih.gov/pubmed/31213670 http://dx.doi.org/10.1038/s41401-019-0257-1 |
Ejemplares similares
-
Huperzine A Ameliorates Cognitive Deficits in Streptozotocin-Induced Diabetic Rats
por: Mao, Xiao-Yuan, et al.
Publicado: (2014) -
Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ(42)-Induced Injury in Primary Rat Neurons
por: Lei, Yun, et al.
Publicado: (2015) -
Huperzine A for treatment of cognitive impairment in major depressive disorder: a systematic review of randomized controlled trials
por: ZHENG, Wei, et al.
Publicado: (2016) -
Examining the Interactome of Huperzine A by Magnetic Biopanning
por: Guo, Wei, et al.
Publicado: (2012) -
Global transcriptome analysis of Huperzia serrata and identification of critical genes involved in the biosynthesis of huperzine A
por: Yang, Mengquan, et al.
Publicado: (2017)